Is CBD Legal in Ohio? Ohio Cannabis, Hemp, and CBD Laws (2026)

Compliant hemp CBD can be sold in Ohio, but the current rules require more than a low delta-9 THC percentage. Senate Bill 56 narrowed the state’s hemp definition from March 20, 2026. Subsequent court orders protect specified plaintiffs and people handling their federally lawful products from certain enforcement, making the position more complex than a blanket statewide ban.

This guide separates the statutory hemp rules, litigation exceptions and licensed medical and adult-use cannabis markets. For national background, see CBD’s status across the United States.

Is CBD Legal in Ohio?

Ohio permits compliant hemp products without a medical card. Its current hemp definition sets a 0.3% total-THC concentration requirement, including THCA, and excludes finished cannabinoid products above 0.4 mg per container of combined THC, THCA and designated similar-effect cannabinoids.

The definition also excludes specified synthesized or externally manufactured cannabinoids, independently of potency. Thus, meeting the container threshold alone is insufficient. CBD itself does not produce THC’s characteristic high, but a CBD formulation can contain enough THC to affect its legal category.

Our delta-8 guide provides state comparisons. A product leaving Ohio’s hemp definition does not automatically become eligible for sale at a licensed marijuana dispensary.

Senate Bill 56 and the Dispensary Supply Chain

SB 56 took effect March 20, 2026. It replaced the broader hemp definition with the requirements above. The statutory change affects some full-spectrum CBD as well as products marketed for intoxication; ordinary wellness marketing does not create an exemption.

Licensed marijuana dispensaries source products through Ohio’s regulated supply chain. An outside hemp manufacturer cannot simply relabel noncompliant stock as marijuana and deliver it to a dispensary. Conversely, a low-THC CBD label is not evidence that a product meets hemp manufacturing and composition requirements.

The governor vetoed the proposed temporary hemp-beverage provisions. That proposed grace period did not become general sales authorization. The later court orders are a separate development.

July and September Court Orders Limit Enforcement

In Titan Logistics Group v. Tischler, the federal court issued a preliminary injunction on July 13, 2026. It restricts enforcement tied to SB 56’s hemp definition against the named plaintiffs and people possessing, selling, distributing or consuming their products, while those products qualify as hemp under federal law.

A September 4 preliminary injunction in Delta Beverages v. Canepa provides similar protection for that case’s plaintiffs and their federally lawful products. The court found likely discrimination against interstate commerce; it did not finally resolve the litigation.

These orders are not universal permission for every manufacturer or product. A business claiming coverage should identify the relevant plaintiff, product and current order. Nor do the orders excuse noncompliance with federal law. Avoid both extremes: saying the entire statute has disappeared or saying no affected hemp product can be sold anywhere in Ohio.

Federal Hemp Changes Have Two Effective Dates

The 2025 federal amendments include a finished-product exclusion above 0.4 mg per container of combined THC, THCA and specified similar-effect cannabinoids, alongside manufacturing exclusions. That threshold is not a CBD-dose cap or a per-serving allowance.

Section 2019 of the September extension delays most provisions until December 11, 2026. Exclusions for cannabinoids the cannabis plant cannot naturally produce remain scheduled for November 12.

The federal delay does not itself rewrite Ohio’s March statute. It also matters to the injunctions because their protection depends on products remaining federally lawful hemp. Full-spectrum CBD is not automatically unaffected.

Assess the Formulation, Not Just the CBD Label

Terms such as isolate, broad-spectrum and full-spectrum describe composition imperfectly. Verify the batch report, total cannabinoid content and manufacturing route. A broad-spectrum label is not proof of zero THC, and a full-spectrum product must be assessed against the actual container threshold and any applicable court protection.

There is also a separate federal sales issue: the FDA prohibits adding CBD to food in interstate commerce and marketing CBD as a dietary supplement. State hemp status does not remove those restrictions or establish medical effectiveness.

Age Rules Depend on the Sales Category

Ohio’s ordinary compliant-hemp framework does not establish a single general CBD purchase age; retailer policies and applicable product rules still matter. Adult-use marijuana purchases require age 21 or older.

Medical marijuana is not limited to people 21 and older. The patient-registration rules provide for adult patients and qualifying minors, with parental or legal-representative consent and caregiver registration for minors. Age checks do not make a prohibited product lawful.

Can Doctors Recommend CBD or Medical Marijuana in Ohio?

Yes. Epidiolex is an FDA-approved prescription CBD medicine, separate from Ohio’s medical marijuana program. Physicians who hold a Certificate to Recommend from the State Medical Board of Ohio can recommend medical marijuana — including marijuana-derived CBD oil — to patients with a qualifying condition. Ohio’s medical program began under House Bill 523 in 2016 and is now run by the Division of Cannabis Control.

The state recognizes specified qualifying medical conditions. They include cancer, epilepsy and other seizure disorders, chronic and severe or intractable pain, multiple sclerosis, Crohn’s disease, Parkinson’s disease, post-traumatic stress disorder, HIV/AIDS, glaucoma, fibromyalgia, sickle cell anemia, Tourette’s syndrome, ulcerative colitis, traumatic brain injury, and chronic traumatic encephalopathy. The State Medical Board can add new conditions through a yearly petition window that runs from November 1 to December 31.

Adult-Use Marijuana and Marijuana-Derived CBD

Ohio voters approved Issue 2 on November 7, 2023, with about 57% support, making Ohio the 24th state to legalize recreational marijuana. The measure took effect on December 7, 2023, and adult-use retail sales began on August 6, 2024. Under the current possession statute, adult-use and homegrown marijuana count cumulatively toward the 2.5-ounce plant-material and 15-gram extract limits. Adults may obtain regulated products from licensed dispensaries, and grow up to six plants at home, with a cap of 12 per household.

The Division of Cannabis Control regulates the market, and Senate Bill 56 placed both the adult-use and medical programs under that single agency. Adult-use purchases carry a 10% excise tax on top of regular state and local sales tax, while registered medical patients are exempt from the excise tax. For the full picture of possession limits, home grow, and penalties, see our guide to cannabis laws in Ohio. Marijuana-derived CBD is available to adults and patients through these dispensaries.

Checking an Ohio CBD Purchase

For ordinary hemp CBD, verify compliance with the current definition and applicable sales rules. If a seller relies on litigation protection, ask which plaintiff’s product is involved and which order covers it. Mere online availability does not establish that protection.

For marijuana products, use the licensed dispensary system and follow the relevant medical or adult-use requirements. A laboratory report should match the exact batch and show the quantities relevant to the entire container, but testing alone does not establish all legal requirements or effectiveness for a health condition.